JPS55149237A - Thymopoietin active peptide - Google Patents

Thymopoietin active peptide

Info

Publication number
JPS55149237A
JPS55149237A JP4699080A JP4699080A JPS55149237A JP S55149237 A JPS55149237 A JP S55149237A JP 4699080 A JP4699080 A JP 4699080A JP 4699080 A JP4699080 A JP 4699080A JP S55149237 A JPS55149237 A JP S55149237A
Authority
JP
Japan
Prior art keywords
active peptide
thymopoietin
thymopoietin active
peptide
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4699080A
Other languages
Japanese (ja)
Other versions
JPH0135839B2 (en
Inventor
Goorudoshiyutain Gideon
Hebunaa Jiyooji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS55149237A publication Critical patent/JPS55149237A/en
Publication of JPH0135839B2 publication Critical patent/JPH0135839B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP4699080A 1979-04-12 1980-04-11 Thymopoietin active peptide Granted JPS55149237A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2959579A 1979-04-12 1979-04-12

Publications (2)

Publication Number Publication Date
JPS55149237A true JPS55149237A (en) 1980-11-20
JPH0135839B2 JPH0135839B2 (en) 1989-07-27

Family

ID=21849861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4699080A Granted JPS55149237A (en) 1979-04-12 1980-04-11 Thymopoietin active peptide

Country Status (2)

Country Link
JP (1) JPS55149237A (en)
ZA (1) ZA802170B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6118799A (en) * 1984-06-27 1986-01-27 オーソ・フアーマシユーチカル・コーポレーシヨン Effective thymopentin analogue
JPH07165791A (en) * 1983-11-18 1995-06-27 Ortho Pharmaceut Corp Enzyme-resistant immune-modulated peptide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0423300U (en) * 1990-04-13 1992-02-26

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE864121A (en) * 1977-11-15 1978-08-21 Sloan Kettering Inst Cancer COMPOSITIONS OF POLYPEPTIDES CONTAINING THE L-ARGININE-L-LYSINE- (L-ASPARTIC ACID) -L-VALINE-L-TYROSINE SEQUENCE, THE PROCESS OF OBTAINING THEM AND THERAPEUTIC COMPOSITIONS CONTAINING

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE864121A (en) * 1977-11-15 1978-08-21 Sloan Kettering Inst Cancer COMPOSITIONS OF POLYPEPTIDES CONTAINING THE L-ARGININE-L-LYSINE- (L-ASPARTIC ACID) -L-VALINE-L-TYROSINE SEQUENCE, THE PROCESS OF OBTAINING THEM AND THERAPEUTIC COMPOSITIONS CONTAINING

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165791A (en) * 1983-11-18 1995-06-27 Ortho Pharmaceut Corp Enzyme-resistant immune-modulated peptide
JPS6118799A (en) * 1984-06-27 1986-01-27 オーソ・フアーマシユーチカル・コーポレーシヨン Effective thymopentin analogue

Also Published As

Publication number Publication date
ZA802170B (en) 1981-11-25
JPH0135839B2 (en) 1989-07-27

Similar Documents

Publication Publication Date Title
IL61037A0 (en) Biologically active peptides
PH15683A (en) Immunopotentiating peptides
DE3375143D1 (en) Peptides
MY8500260A (en) Biologically active peptides
PH17006A (en) Pharmacollogically active peptides
DE3377654D1 (en) Hypocholesterolemically active protein
JPS5697256A (en) Pharmacutically active peptides
JPS5697255A (en) Pharmacutically active peptides
JPS5697257A (en) Pharmaceutically active peptides
PT71087A (en) Peptides having thymopoietin-like activity
GB8319305D0 (en) Synthetic peptides
JPS5697258A (en) Pharmaceutically active peptides
GB8329425D0 (en) Peptides
GB2086396B (en) Biologically active peptides
DE3264659D1 (en) Biologically active peptides
JPS55149237A (en) Thymopoietin active peptide
ZA837454B (en) Peptides
ZA805789B (en) Biologically active peptides
GB2118190B (en) Peptides with sauvagine-like activity
JPS5671054A (en) Novel cyclopeptide
JPS5677248A (en) Peptides
ZA838315B (en) Peptides
JPS54163575A (en) Novel peptide
JPS54144367A (en) Novel peptide
IE782425L (en) Peptides